POMGNT2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: By analyzing the pathological alterations in the early developmental stages of the Pomgnt2-KO mouse brain, we provide deeper insights into how loss of dystroglycan function gives rise to the brain malformations in dystroglycanopathy.